Laser Acupuncture for Behavioral and Psychological Symptoms of Dementia

NCT ID: NCT07204145

Last Updated: 2025-10-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-01

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study uses a laser acupuncture pen to stimulate specific acupoints, aiming to evaluate its effectiveness in improving behavioral and psychological symptoms of dementia (BPSD).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be dementia patients residing in institutions who present with BPSD symptoms. A laser acupuncture pen with a wavelength of 808 nm will be used to irradiate the following acupoints three times per week: GV20, ST36, and PC6, with each acupoint irradiated for 10 seconds per session. The severity of BPSD, activities of daily living, and cognitive function will be assessed using the NPI, MMSE, and ADL scales, respectively, while recording the dosage of oral Psychotropic medicationsmedications. A total of six assessments, including the baseline, will be conducted to evaluate the immediate, short-term, and long-term effects of laser acupuncture.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Behavioral and Psychological Symptoms of Dementia (BPSD) Dementia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be randomly assigned in a parallel design to one of three groups: laser acupuncture, sham laser acupuncture, or usual care. The interventions will be delivered concurrently, and outcomes will be assessed at baseline and five follow-up time points.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors
Participants, care providers, and outcome assessors will be masked to group assignment. The investigator delivering the intervention will be aware of the assignment due to the nature of the laser acupuncture procedure.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Laser Acupuncture

Participants receive laser acupuncture with an 808 nm laser pen at GV20, ST36, and PC6, three times per week, 10 seconds per acupoint.

Group Type EXPERIMENTAL

Laser Acupuncture (808 nm laser pen)

Intervention Type DEVICE

Participants receive laser acupuncture using an 808 nm, 100 mW semiconductor laser pen applied at acupoints GV20, bilateral ST36, and bilateral PC6. Each acupoint is irradiated for 10 seconds, three times per week, for 12 weeks.

Sham Laser Acupuncture

Participants receive sham laser acupuncture with the same procedure but without active laser output.

Group Type PLACEBO_COMPARATOR

Sham Laser Acupuncture

Intervention Type DEVICE

Participants receive the same procedure as the laser acupuncture group, using an 808 nm semiconductor laser pen applied at acupoints GV20, bilateral ST36, and bilateral PC6. The device is identical in appearance and produces lights and beeping sounds; however, it delivers no energy output. Each acupoint is contacted for 10 seconds, three times per week, for 12 weeks.

Usual Care

Participants receive standard dementia care provided by the facility, including routine medical treatment, nursing care, and daily support, without additional acupuncture or laser intervention.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laser Acupuncture (808 nm laser pen)

Participants receive laser acupuncture using an 808 nm, 100 mW semiconductor laser pen applied at acupoints GV20, bilateral ST36, and bilateral PC6. Each acupoint is irradiated for 10 seconds, three times per week, for 12 weeks.

Intervention Type DEVICE

Sham Laser Acupuncture

Participants receive the same procedure as the laser acupuncture group, using an 808 nm semiconductor laser pen applied at acupoints GV20, bilateral ST36, and bilateral PC6. The device is identical in appearance and produces lights and beeping sounds; however, it delivers no energy output. Each acupoint is contacted for 10 seconds, three times per week, for 12 weeks.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of Dementia: Participants must have a clinical diagnosis of dementia, of any type or severity
* Consent: Written informed consent provided by the participant's family or legal representative.

Exclusion Criteria

* Refusal to sign the informed consent form.
* Unable to cooperate with the intervention procedure despite repeated attempts.
* History of epilepsy.
* End-stage liver disease.
* End-stage renal disease requiring hemodialysis.
* Presence of brain tumor or history of major brain surgery.
* Acute cardiovascular or cerebrovascular events within the past 3 months (e.g., unstable angina, myocardial infarction, stroke).
* Use of a cardiac pacemaker.
* Currently receiving acupuncture or traditional Chinese medicine treatment.
* Presence of acute illness.
* Abnormal blood pressure or fever.
* Presence of malignant tumor.
* Pregnancy.
* Presence of unusual physical abnormalities or sensory nerve disorders.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

China Medical University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yu-Chen Lee

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yuchen Lee, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Principal Investigator, Department of Acupuncture

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Taoyuan Veteran's Home

Taoyuan, Bade District, Taiwan

Site Status

China Medical University Hospital

Taichung, Taichung City, Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Professor of Acupuncture, China Medical University, MD, PhD

Role: CONTACT

+886-4-2205-2121

shu-yun Tang, MS, RN

Role: CONTACT

+886920455281

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Head of Health Care Section

Role: primary

+886-3-3681140 ext. 295

Clinical Trial Office, China Medical University Hospital

Role: primary

+886-4-2205-2121

shu-yun Research Coordinator

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CMUH114-REC3-115

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effectiveness of Doll Therapy in People With Dementia
NCT06506487 ACTIVE_NOT_RECRUITING NA